Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study

Marianne Benn; Børge G Nordestgaard; Gorm Boje Jensen; Anne Tybjaerg-Hansen

doi:10.1161/01.ATV.0000255580.73689.8e

Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study

Marianne Benn, Børge G Nordestgaard, Gorm Boje Jensen, Anne Tybjaerg-Hansen

134 Citations (Scopus)

Abstract

Apolipoprotein B (apoB) levels predict fatal myocardial infarction. Whether apoB also predicts nonfatal ischemic cardiovascular events is unclear. We tested the following hypotheses: apoB predicts ischemic cardiovascular events, and apoB is a better predictor of ischemic cardiovascular events than low-density lipoprotein cholesterol.

Original language	English
Journal	Arteriosclerosis, Thrombosis, and Vascular Biology
Volume	27
Issue number	3
Pages (from-to)	661-70
Number of pages	10
ISSN	1079-5642
DOIs	https://doi.org/10.1161/01.ATV.0000255580.73689.8e
Publication status	Published - 2007

Keywords

Adult
Age Distribution
Aged
Aged, 80 and over
Apolipoproteins B
Biological Markers
Cholesterol, LDL
Cohort Studies
Female
Humans
Incidence
Ischemic Attack, Transient
Male
Middle Aged
Myocardial Infarction
Myocardial Ischemia
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Risk Assessment
Sensitivity and Specificity
Severity of Illness Index
Sex Distribution
Stroke

Access to Document

10.1161/01.ATV.0000255580.73689.8e

http://atvb.ahajournals.org/cgi/content/full/27/3/661

Cite this

Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study. / Benn, Marianne ; Nordestgaard, Børge G; Jensen, Gorm Boje et al.
In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, No. 3, 2007, p. 661-70.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{c5c35a99024f4f00b0c48f527aae32c3,

title = "Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study",

abstract = "Apolipoprotein B (apoB) levels predict fatal myocardial infarction. Whether apoB also predicts nonfatal ischemic cardiovascular events is unclear. We tested the following hypotheses: apoB predicts ischemic cardiovascular events, and apoB is a better predictor of ischemic cardiovascular events than low-density lipoprotein cholesterol.",

keywords = "Adult, Age Distribution, Aged, Aged, 80 and over, Apolipoproteins B, Biological Markers, Cholesterol, LDL, Cohort Studies, Female, Humans, Incidence, Ischemic Attack, Transient, Male, Middle Aged, Myocardial Infarction, Myocardial Ischemia, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Sex Distribution, Stroke",

author = "Marianne Benn and Nordestgaard, {B{\o}rge G} and Jensen, {Gorm Boje} and Anne Tybjaerg-Hansen",

year = "2007",

doi = "10.1161/01.ATV.0000255580.73689.8e",

language = "English",

volume = "27",

pages = "661--70",

journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",

issn = "1079-5642",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

TY - JOUR

T1 - Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B

T2 - the Copenhagen City Heart Study

AU - Benn, Marianne

AU - Nordestgaard, Børge G

AU - Jensen, Gorm Boje

AU - Tybjaerg-Hansen, Anne

PY - 2007

Y1 - 2007

N2 - Apolipoprotein B (apoB) levels predict fatal myocardial infarction. Whether apoB also predicts nonfatal ischemic cardiovascular events is unclear. We tested the following hypotheses: apoB predicts ischemic cardiovascular events, and apoB is a better predictor of ischemic cardiovascular events than low-density lipoprotein cholesterol.

AB - Apolipoprotein B (apoB) levels predict fatal myocardial infarction. Whether apoB also predicts nonfatal ischemic cardiovascular events is unclear. We tested the following hypotheses: apoB predicts ischemic cardiovascular events, and apoB is a better predictor of ischemic cardiovascular events than low-density lipoprotein cholesterol.

KW - Adult

KW - Age Distribution

KW - Aged

KW - Aged, 80 and over

KW - Apolipoproteins B

KW - Biological Markers

KW - Cholesterol, LDL

KW - Cohort Studies

KW - Female

KW - Humans

KW - Incidence

KW - Ischemic Attack, Transient

KW - Male

KW - Middle Aged

KW - Myocardial Infarction

KW - Myocardial Ischemia

KW - Predictive Value of Tests

KW - Prognosis

KW - Proportional Hazards Models

KW - Risk Assessment

KW - Sensitivity and Specificity

KW - Severity of Illness Index

KW - Sex Distribution

KW - Stroke

U2 - 10.1161/01.ATV.0000255580.73689.8e

DO - 10.1161/01.ATV.0000255580.73689.8e

M3 - Journal article

C2 - 17170368

SN - 1079-5642

VL - 27

SP - 661

EP - 670

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

IS - 3

ER -

Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study

Abstract

Keywords

Access to Document

Fingerprint

Cite this